Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL3 | Q96JM7 | 2/20 | 0.48 |
| ▸ | CPN1 | P15169 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.33 |
| ▸ | CDY1; CDY1B | Q9Y6F8 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | USP5 | P45974 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13349247 | 0.80 | L3MBTL3 (0.47) | L3MBTL3CPN1CPB2L3MBTL1 | |
| SCHEMBL22699009 | 0.77 | L3MBTL3 (0.48) | L3MBTL3L3MBTL1CDYLCDY1; CDY1BHDAC4 | |
| SCHEMBL4550247 | 0.77 | L3MBTL3 (0.58) | L3MBTL3L3MBTL1 | |
| SCHEMBL22878132 | 0.76 | L3MBTL3 (0.56) | L3MBTL3L3MBTL1CDYLCDY1; CDY1BHDAC4 | |
| SCHEMBL27781047 | 0.74 | L3MBTL3 (0.60) | L3MBTL3L3MBTL1CDYLCDY1; CDY1BHDAC4 | |
| SCHEMBL14344738 | 0.74 | CPN1 (0.41) | CPN1CPB2 | |
| SCHEMBL3318797 | 0.73 | CPN1 (0.47) | CPN1CPB2 | |
| SCHEMBL1149395 | 0.73 | PHGDH (0.48) | CPN1CPB2 | |
| SCHEMBL3318800 | 0.73 | CPN1 (0.43) | CPN1CPB2L3MBTL1 | |
| SCHEMBL14344826 | 0.73 | CPN1 (0.43) | CPN1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4180061-A1 | ANTHRACYCLINE DERIVATIVE LINKER REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS | Nerviano Medical Sciences S.r.l. (IT) | 2023-05-17 | — | — | EP | disclosed |
| US-7312235-B2 | Benzamide inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-12-25 | — | — | US | disclosed |
| US-7312235-B2 | Benzamide inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-12-25 | — | — | US | disclosed |